Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proellex in symptomatic uterine fibroids
NCT00853567Phase 3Terminated
- Sponsor
- Repros Therapeutics Inc.
- Start
- Feb 2009
- Primary completion
- Aug 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of telapristone in Uterine Fibroids (UF), sponsored by Repros Therapeutics Inc.. Started Feb 2009; status: terminated.
02
Drugs
telapristone
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT00853567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00853567.